Impact Factor 4.225 | CiteScore 5.0
More on impact ›

CORRECTION article

Front. Pharmacol., 22 April 2021 | https://doi.org/10.3389/fphar.2021.671318

Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy

www.frontiersin.orgJingxue Ye1, www.frontiersin.orgShan Lu1, www.frontiersin.orgMin Wang1, www.frontiersin.orgWenxiu Ge2, www.frontiersin.orgHaitao Liu1, www.frontiersin.orgYaodong Qi1, www.frontiersin.orgJianhua Fu3, www.frontiersin.orgQiong Zhang3, www.frontiersin.orgBengang Zhang1*, www.frontiersin.orgGuibo Sun1* and www.frontiersin.orgXiaobo Sun1*
  • 1Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 2College of Pharmacy, Harbin University of Commerce, Harbin, China
  • 3Pneumology Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China

A Corrigendum on
Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy

by Jingxue Ye, Shan Lu, Min Wang, Wenxiu Ge, Haitao Liu, Yaodong Qi, Jianhua Fu, Qiong Zhang, Bengang Zhang, Guibo Sun, and Xiaobo Sun (2020). Front. Pharmacol. 11:1170. doi:10.3389/fphar.2020.01170

There is an error in the Funding Statement. The correct number for “National Natural Sciences Foundation of China” is “81673817”.

The authors apologize for this error and state that this does not change the scientific conclusion of the article in any way. The original article has been updated.

Keywords: myocardial ischemia reperfusion injury, hydroxysafflor yellow A, NLRP3, autophagy, AMPK

Citation: Ye J, Lu S, Wang M, Ge W, Liu H, Qi Y, Fu J, Zhang Q, Zhang B, Sun G and Sun X (2021) Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy. Front. Pharmacol. 12:671318. doi: 10.3389/fphar.2021.671318

Received: 23 February 2021; Accepted: 07 April 2021;
Published: 22 April 2021.

Edited by:

Francesco Rossi, University of Campania Luigi Vanvitelli, Italy

Reviewed by:

Xiang Gao, Cornell University, United States
Tapas C Nag, All India Institute of Medical Sciences, India

Copyright © 2021 Ye, Lu, Wang, Ge, Liu, Qi, Fu, Zhang, Zhang, Sun and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Bengang Zhang, bgzhang@implad.ac.cn; Guibo Sun, sunguibo@126.com; Xiaobo Sun, sun_xiaobo163@163.com

These authors have contributed equally to this work